Ivabradine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ivabradine Hydrochloride
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Ivabradine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 11 USDMF, 1 JDMF, 9 EU WC, 4 KDMF, 7 NDC API, 28 Listed Suppliers, $ API Reference Price

37 API Suppliers
11 USDMF
1 JDMF
9 EU WC
4 KDMF
7 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

32 Intermediate Suppliers

32 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

131 FDF Dossiers, 13 FDA Orange Book, 73 Europe, 2 Canada, 5 Australia, 6 South Africa, 32 Listed Dossiers

131 FDF Dossiers
13 FDA Orange Book
73 Europe
2 Canada
5 Australia
6 South Africa
32 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 4 SPI Pharma, 3 DKSH, 4 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 4 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 26 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 5 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 The Dow Chemical Company, 1 Vasa Pharmachem

2 EUROAPI
1 Rochem International Inc
4 SPI Pharma
3 DKSH
4 Faran Shimi Pharmaceutical
2 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 ACG Worldwide
3 Actylis
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
2 DFE Pharma
4 Gangwal Chemicals
4 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
26 Kerry
3 Kima Chemical
6 Lonza Capsugel
8 Microlex e.U
1 Novo Excipients
5 Pluviaendo
1 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
13 Roquette
7 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
3 Sigachi Industries
2 The Dow Chemical Company
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 16 Controlled & Modified Release, 11 Direct Compression, 11 Lubricants & Glidants, 9 Film Formers & Plasticizers, 8 Granulation, 8 Taste Masking, 6 Thickeners and Stabilizers, 5 Chewable & Orodispersible Aids, 5 Parenteral, 5 Co-Processed Excipients, 5 Empty Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Solubilizers, 3 Topical, 1 Rheology Modifiers

45 Fillers, Diluents & Binders
42 Coating Systems & Additives
16 Controlled & Modified Release
11 Direct Compression
11 Lubricants & Glidants
9 Film Formers & Plasticizers
8 Granulation
8 Taste Masking
6 Thickeners and Stabilizers
5 Chewable & Orodispersible Aids
5 Parenteral
5 Co-Processed Excipients
5 Empty Capsules
4 Coloring Agents
4 Emulsifying Agents
4 Disintegrants & Superdisintegrants
4 Vegetarian Capsules
4 API Stability Enhancers
3 Solubilizers
3 Topical
1 Rheology Modifiers

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 57 Finished Drug Prices

1 US Medicaid Prescriptions
57 Finished Drug Prices

MARKET PLACE

13 APIs, 3 FDF Dossiers

13 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 2 US Exclusivities, 14 Health Canada Patents

20 US Patents
2 US Exclusivities
14 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 6,432 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

20 All

01 20AMGEN INC

filter Patent Number Reset all filters

20 All

01 37361649

02 27361649*PED

03 37361650

04 27361650*PED

05 37867996

06 27867996*PED

07 37879842

08 27879842*PED

filter API Patent Reset all filters

20 All

01 12Y

02 8Blank

filter FDF Patent Reset all filters

20 All

01 12Y

02 8Blank

filter Expiration Date Reset all filters

20 All

01 92026-02-22

02 62026-08-22

03 32026-12-12

04 22027-06-12

Product Main Page

01

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-12

IVABRADINE HYDROCHLORIDE

US Patent Number : 7867996

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7879842

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7879842

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AMGEN INC

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-12

US Patent Number : 7867996

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

AMGEN INC

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

AMGEN INC

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

AMGEN INC

IVABRADINE HYDROCHLORIDE

The Generic Rx Session

Not Confirmed

AMGEN INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-22

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!